Related Experiment Video
Updated: Jun 13, 2026

Glucose Uptake Measurement and Response to Insulin Stimulation in In Vitro Cultured Human Primary Myotubes
Published on: June 25, 2017
Palmitate induced insulin resistance by PKCtheta-dependent activation of mTOR/S6K pathway in C2C12 myotubes
Abstract:
The underlying mechanism of palmitate-induced insulin resistance in skeletal muscle cells is obscure. In this study, we showed that palmitate inhibited the insulin signaling in C2C12 myotubes, accompanied with the enhanced phosphorylation of protein kinase C-theta (PKCΘ). The inhibitory effects of palmitate on the insulin signaling were diminished in PKCΘ- and mTOR (mammalian target of rapamycin)-deficient C2C12 myotubes, and C2C12 myotubes pre-treated with rapamycin. In addition, the phosphorylation of mTOR and p70 ribosomal S6 kinase (S6K) enhanced by palmitate was attenuated in PKCΘ-deficient C2C12 myotubes and in C2C12 myotubes treated with PKCΘ pseudosubstrate. Taken together, our results suggested that palmitate-induced insulin resistance in C2C12 myotubes is mediated by PKCΘ/mTOR/S6K pathway.
Insights
Palmitate triggers insulin resistance in muscle cells via the protein kinase C-theta (PKCΘ) and mammalian target of rapamycin (mTOR) pathway, impacting S6K phosphorylation.
Area of Science:
- Molecular Biology
- Cellular Metabolism
- Endocrinology
Background:
- Insulin resistance in skeletal muscle is a key factor in type 2 diabetes.
- The precise molecular mechanisms driving palmitate-induced insulin resistance remain unclear.
- Skeletal muscle insulin sensitivity is crucial for glucose homeostasis.
Purpose of the Study:
- To elucidate the mechanism of palmitate-induced insulin resistance in skeletal muscle cells.
- To investigate the role of protein kinase C-theta (PKCΘ) and mammalian target of rapamycin (mTOR) in this process.
- To identify key signaling pathways involved in palmitate's effects on insulin signaling.
Main Methods:
- Utilized C2C12 myotubes as a model system for skeletal muscle cells.
- Examined the effects of palmitate exposure on insulin signaling pathways.
- Employing genetic deficiency (PKCΘ- and mTOR-deficient cells) and pharmacological inhibition (rapamycin, PKCΘ pseudosubstrate).
- Assessed protein phosphorylation of key signaling molecules including PKCΘ, mTOR, and S6K.
Main Results:
- Palmitate inhibited insulin signaling in C2C12 myotubes.
- This inhibition was associated with increased PKCΘ phosphorylation.
- Deficiency in PKCΘ or mTOR, or rapamycin treatment, diminished palmitate's inhibitory effects.
- Palmitate-induced phosphorylation of mTOR and S6K was reduced in PKCΘ-deficient cells or with PKCΘ pseudosubstrate treatment.
Conclusions:
- Palmitate-induced insulin resistance in skeletal muscle cells is mediated by the PKCΘ/mTOR/S6K signaling pathway.
- PKCΘ plays a critical role in transmitting palmitate's inhibitory signals on insulin action.
- Targeting the PKCΘ/mTOR/S6K pathway may offer therapeutic strategies for managing insulin resistance.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Insulin: The Receptor and Signaling Pathways
cAMP-dependent Protein Kinase Pathways
Type II Diabetes II: Pathophysiology
Insulin Secretory Vesicles
